MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
16.34
-0.07
-0.43%
Closed 19:56 12/17 EST
OPEN
16.35
PREV CLOSE
16.41
HIGH
17.14
LOW
16.01
VOLUME
4.76M
TURNOVER
0
52 WEEK HIGH
21.73
52 WEEK LOW
5.28
MARKET CAP
2.99B
P/E (TTM)
-22.1920
1D
5D
1M
3M
1Y
5Y
1D
3 Stocks Flashing Strong Buy Signals, Backed by Technical Analysis
TipRanks · 19h ago
Sarepta rises as HHS adds Duchenne muscular dystrophy to newborn screenings
Seeking Alpha · 1d ago
Wave Life Sciences Is Maintained at Outperform by Oppenheimer
Dow Jones · 1d ago
Oppenheimer Maintains Outperform on WAVE Life Sciences, Raises Price Target to $32
Benzinga · 1d ago
WAVE LIFE SCIENCES LTD. <WVE.O>: OPPENHEIMER RAISES TARGET PRICE TO $32 FROM $24
Reuters · 1d ago
Wave Life Sciences price target raised to $32 from $24 at Oppenheimer
TipRanks · 1d ago
GlaxoSmithKline Makes a Bold Move with Major Wave Life Sciences Stock Purchase!
TipRanks · 2d ago
GSK plc Reports Acquisition of Common Shares in Wave Life Sciences Ltd
Reuters · 2d ago
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.